OXX is well on track in achieving its new business goal. Ophir is just the beginning. I believe the next project will be even more rewarding.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025